Enroll
in a Clinical Trial
The following NEALS affiliated studies are currently enrolling
patients:
Phase 2 Trial of Ezogabine (Retigabine)
Phase 2 Trial of Tocilizumab (Actemra)
Phase 2 Trial of Ibudilast (MN-166)
Phase 2 Trial of Mexiletine
Phase 2 Trial of NP001
CNS10-NPC-GDNF for the Treatment of ALS
Electronic-health Application To Measure Outcomes Remotely (EAT MORE)
Answer ALS: Individualized Initiative for ALS Discovery
Cross-Sectional ALS Biofluid Biomarker Study (CABB)
Imaging and Biofluid Biomarkers (TRACK ALS)
Defining Clinical Characteristics in C9ORF72 ALS Patients
Microbiome Assessment (MAP ALS)
Hiç yorum yok:
Yorum Gönder